1478877

LÖSUNG VON ORLISTAT-VERWANDTE VERBINDUNG D

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): N-Formyl-L-leucin-(3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-ylester
• Empirische Formel (Hill-System): C₂₉H₅₃NO₅
• CAS-Nummer: 130793-27-0
• Molekulargewicht: 495.73
• MDL-Nummer: MFCD28137837
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• Agentur: USP
• API-Familie: orlistat
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical
• Format: neat
• SMILES String: N([C@@H](CC(C)C)C(=O)O[C@H]1[C@@H](C(=O)O[C@H](C1)CCCCCCCCCCC)CCCCCC)C=O
• InChI: 1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27+/m0/s1
• InChIKey: IYWNIYFHQZQPBP-YIPNQBBMSA-N

Beschreibung

Allgemeine Beschreibung

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Anwendung

Orlistat Related Compound Solution USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Orlistat
• Orlistat Capsules

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS02,GHS07
• Signalwort: Danger
• H-Sätze: H225,H302 + H312 + H332,H319
• P-Sätze: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 2
• Flammpunkt (°F): 35.6 °F - closed cup
• Flammpunkt (°C): 2.0 °C - closed cup